Search company, investor...
Boreal Genomics company logo

Boreal Genomics

Founded Year



Series C | Alive

Total Raised


Last Raised

$18M | 9 yrs ago

About Boreal Genomics

Boreal Genomics develops a blood-based detection platform designed to facilitate non-invasive genomic profiling of tumors from the blood plasma of cancer patients. The platform performs genomic analysis of cell-free DNA in plasma to detect and quantify mutations in tumor-derived circulating nucleic acids. The company was founded in 2007 and is based in Vancouver, Canada.

Headquarters Location

2386 East Mall Suite #300

Vancouver, British Columbia, V6T 1Z3,



Missing: Boreal Genomics's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Boreal Genomics's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing Boreal Genomics

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Boreal Genomics is included in 2 Expert Collections, including Cancer.



3,605 items

Companies researching, developing, or offering products & services that aid in the screening, prevention, diagnosis, management, and treatment of cancer.



1,267 items

Companies involved in the capture, sequencing, and/or analysis of genomic, transcriptomic, proteomic, and/or metabolomic data

Boreal Genomics Patents

Boreal Genomics has filed 19 patents.

The 3 most popular patent topics include:

  • DNA
  • Molecular biology
  • Biotechnology
patents chart

Application Date

Grant Date


Related Topics




Molecular biology, Biotechnology, DNA, DNA sequencing, Molecular biology techniques


Application Date


Grant Date



Related Topics

Molecular biology, Biotechnology, DNA, DNA sequencing, Molecular biology techniques



Latest Boreal Genomics News

Scientist / Senior Scientist: Assay Development

Jan 5, 2022

Description Boreal Genomics is a dynamic biotech company that has developed a revolutionary new approach for NGS target enrichment. This innovation enables rapid and efficient analysis of DNA for applications including oncology, gene editing and single cell genomics. Boreal is expanding its team in conjunction with a major partnership that will enable us to bring this technology to market for the benefit of cancer patients worldwide. Boreal is seeking a highly-motivated and talented scientist to join its assay team and play a leading role in NGS assay development and productization. The successful candidate will be responsible for a wide range of tasks, including assay development, optimization and debugging towards the first product, and implementing manufacturing and productization of the assay. The ideal candidate will know what it takes to release a successful NGS product, and will contribute significantly to the success of the company. This is a fantastic opportunity to join a growing, talented and motivated team, and to make a significant impact in oncology. Our new partnership provides us with sector-leading resources and will allow us to provide highly competitive, long term offers in a growing but stable environment. Job activities include but are not limited to: Working with the broader Boreal team in executing Boreal’s strategy for assay development and release Developing and executing in-lab experimental plans to optimize Boreal’s technology for product release, including basic data analysis Validating and troubleshooting the assay to meet internal specifications Highly detailed tracking of reagents and other lab resources to ensure assay success internally and with customers Preparing Boreal’s assay for commercialization, including developing protocols for reagent QC and handling Maintaining accurate and complete laboratory records, including formal written and oral research progress reporting Qualifications Sc., M.Sc. or PhD in molecular biology or a related field Demonstrated experience in NGS assay development, including the ability to analyze, interpret and troubleshoot experimental NGS data with minimal supervision, but would consider exceptional junior candidates without such experience Excellent interpersonal and communication skills Excellent scientific documentation skills and strong attention to detail Boreal Genomics ( ) are a team of specialists in molecular biology, engineering and physics with a passion to develop technology that advances next-generation sequencing to help cancer researchers and clinicians transform patient care through earlier detection and monitoring of cancer. Boreal is committed to creating faster, more efficient, and practical assays for routine clinical use. Send softcopy resume and cover letter in Word or PDF format to . Please include reference number RES041.

Boreal Genomics Frequently Asked Questions (FAQ)

  • When was Boreal Genomics founded?

    Boreal Genomics was founded in 2009.

  • Where is Boreal Genomics's headquarters?

    Boreal Genomics's headquarters is located at 2386 East Mall, Vancouver.

  • What is Boreal Genomics's latest funding round?

    Boreal Genomics's latest funding round is Series C.

  • How much did Boreal Genomics raise?

    Boreal Genomics raised a total of $24.5M.

  • Who are the investors of Boreal Genomics?

    Investors of Boreal Genomics include ARCH Venture Partners, Kearny Venture Partners, In-Q-Tel, GrowthPath Capital and University of British Columbia.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.